Pancreatic Cancer Research

ResearcherUniversity of MinnesotaActive in the last 2 years

Melena D. Bellin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7324-4837; OpenAlex author ID A5003624987; NIH RePORTER profile ID 8743347. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
3
Labs led
1
Collaborators
81
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 2 papers · 2021: 3 papers · 2022: none · 2023: none · 2024: 1 grant · 2025: 1 paper · 2026: 2 papers, 2 grants

Papers 13

  1. Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancrea… Co-author DOI 10.1016/j.pan.2026.04.001↗
  2. Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for the Study of Chronic Pancreatitis, Diabet… Co-author DOI 10.1097/mpa.0000000000002657↗
  3. Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis. Co-author DOI 10.1007/s00125-025-06543-y↗
  4. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Co-author DOI 10.1038/s43018-021-00268-8↗
  5. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0250539↗
  6. Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis. Co-author DOI 10.14309/ctg.0000000000000431↗
  7. Web-based cognitive-behavioral intervention for pain in pediatric acute recurrent and chronic pancreatitis: Protocol of a multicenter randomized controlled tri… Co-author DOI 10.1016/j.cct.2019.105898↗
  8. Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.cell.2020.03.062↗
  9. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma Co-author DOI 10.1101/663583↗
  10. Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rational… Co-author DOI 10.1097/mpa.0000000000001168↗
  11. INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE Cohort Study: Design and Rationale for INSPPIRE 2 From the Consortium for the Study o… Co-author DOI 10.1097/mpa.0000000000001172↗
  12. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. First author DOI 10.1016/s2468-1253(16)30106-6↗
  13. Metastatic Pancreatic Adenocarcinoma After Total Pancreatectomy Islet Autotransplantation for Chronic Pancreatitis. Co-author DOI 10.1111/ajt.13851↗

Grants 3

  1. PancreasFest 2026 R13DK149552↗
  2. University of Minnesota Clinical Center for the Study of Pancreatic Disease U01DK126300↗
  3. The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center U01DK108327↗

Closest collaborators

The 25 strongest of 81 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gregory J Beilman · 1 shared paper, 1 shared grant, 2016–2026 · strength 1.07
  2. Guru V Trikudanathan · 1 shared grant, 2026 · strength 1.00
  3. Dhiraj Yadav · 5 shared papers, 2016–2026 · strength 0.79
  4. Dana K. Andersen · 5 shared papers, 2016–2026 · strength 0.79
  5. Phil A. Hart · 5 shared papers, 2016–2026 · strength 0.79
  6. Walter Gwang-Up Park · 3 shared papers, 2025–2026 · strength 0.68
  7. José Serrano · 5 shared papers, 2018–2026 · strength 0.62
  8. Mark D. Topazian · 1 shared paper, 1 shared grant, 2024–2026 · strength 0.62
  9. Darwin Lewis Conwell · 1 shared paper, 1 shared grant, 2024–2026 · strength 0.62
  10. Yogish C. Kudva · 4 shared papers, 2016–2026 · strength 0.56
  11. Mark Goodarzi · 4 shared papers, 2016–2026 · strength 0.56
  12. Christopher E Forsmark · 3 shared papers, 2016–2026 · strength 0.52
  13. Stephen Jacob Pandol · 3 shared papers, 2016–2026 · strength 0.52
  14. Evan L Fogel · 2 shared papers, 2026 · strength 0.47
  15. David Clement Whitcomb · 1 shared paper, 1 shared grant, 2018–2024 · strength 0.45
  16. Frederico G. S. Toledo · 2 shared papers, 2025–2026 · strength 0.45
  17. Kenneth Cusi · 2 shared papers, 2025–2026 · strength 0.45
  18. Philip A. Hart · 1 shared grant, 2024 · strength 0.39
  19. Andres Gelrud · 1 shared grant, 2024 · strength 0.39
  20. Pamela G. Banks · 1 shared grant, 2024 · strength 0.39
  21. Cheryl E Gariepy · 1 shared grant, 2024 · strength 0.39
  22. Francis G Gress · 1 shared grant, 2024 · strength 0.39
  23. Joseph Palermo · 1 shared grant, 2024 · strength 0.39
  24. Hanno Steen · 1 shared grant, 2024 · strength 0.39
  25. Peter Alan Banks · 1 shared grant, 2024 · strength 0.39

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.